About: Management von Patienten mit Tracheostoma während der COVID-19-Pandemie: Literaturüberblick und Demonstration

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Management von Patienten mit Tracheostoma während der COVID-19-Pandemie: Literaturüberblick und Demonstration Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Management von Patienten mit Tracheostoma während der COVID-19-Pandemie: Literaturüberblick und Demonstration
Creator	Huebner, · Iro, · Kempfle, J Löwenheim, · Mueller, ·
Source	Medline; PMC
abstract	BACKGROUND: Since emergence of the new coronavirus in China in December 2019, many countries have been struggling to control skyrocketing numbers of infections, including among healthcare personnel. It has now been clearly demonstrated that SARS-CoV‑2 resides in the upper airways and transmits easily via aerosols and droplets, which significantly increases the risk of infection when performing upper airway procedures. Ventilated COVID-19 patients in a critical condition in the intensive care unit may require tracheotomy for long-term ventilation and to improve weaning. However, the risk of secondary infection of medical personnel performing subsequent tracheostomy care remains unclear. OBJECTIVE: This study aimed to evaluate the risk of droplet dispersion during tracheostomy tube change and overview tracheostomy tube change in COVID-19 patients. MATERIALS AND METHODS: The current literature was reviewed, quantitative and qualitative analyses of droplet formation during tracheostomy tube change in n = 8 patients were performed, and an overview of and checklist for tracheostomy tube change were compiled. RESULTS: This study demonstrates that tracheostomy tube change, in particular insertion of the new tube, may cause significant droplet formation. The aerosolization of particles smaller than 5 µm was not analyzed. CONCLUSION: Our data, together with the current literature, clearly emphasize that tracheostomy care is associated with a high infection risk and should only be performed by a small group of well-trained, maximally protected healthcare personnel.
has issue date	2020-06-08(xsd:dateTime)
bibo:doi	10.1007/s00106-020-00892-3
bibo:pmid	32514605
has license	cc-by
sha1sum (hex)	fe1d55d0e2ffc71f190c81b6b358247692f14e91
schema:url	https://doi.org/10.1007/s00106-020-00892-3
resource representing a document's title	Management von Patienten mit Tracheostoma während der COVID-19-Pandemie: Literaturüberblick und Demonstration
has PubMed Central identifier	PMC7278214
has PubMed identifier	32514605
schema:publication	HNO
resource representing a document's body	covid:fe1d55d0e2ffc71f190c81b6b358247692f14e91#body_text
is schema:about of	named entity 'Demonstration' named entity 'bei' named entity 'oder' named entity 'fand' named entity 'COVID-19' named entity 'tracheostomy' named entity 'bieten' named entity 'Intubation' named entity 'MERS' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'SARS' named entity 'seinen' named entity 'SARS-CoV-2' named entity 'Sputum' named entity 'SARS-CoV-1' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'aerosolization' named entity 'oder' named entity 'SARS' named entity 'Nature Medicine' named entity 'Coronavirus 2' named entity 'BAuA' named entity 'SARS-CoV-2' named entity 'biosafety level' named entity 'SARS-CoV-2' named entity 'SARS' named entity 'die Nase' named entity 'powered air purifying respirator' named entity 'SARS-CoV-2' named entity 'Bundesministerium für Arbeit und Soziales' named entity 'HEPA' named entity 'current literature' named entity 'oder' named entity 'oder' named entity 'Severe Acute Respiratory Syndrome' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'RKI' named entity 'oder' named entity 'Robert Koch-Institut' named entity 'ARDS' named entity 'SARS-CoV-2' named entity 'Middle East Respiratory Syndrome' named entity 'oder' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'Berlin' named entity 'tracheostomy tube' named entity 'SARS-CoV-2' named entity 'BAuA' named entity 'tracheostomy tube' named entity 'vorab' named entity 'oder' named entity 'current literature' named entity 'SARS-CoV-2' named entity 'Weaning' named entity 'SARS-CoV-2' named entity 'oder' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'SARS' named entity 'acute respiratory distress syndrome' named entity 'RKI' named entity 'oder' named entity 'SARS-CoV-1' named entity 'COVID-19' named entity 'tracheostomy tube' named entity 'oder' named entity 'Robert Koch' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'SARS-CoV-2' named entity 'SARS' named entity 'COVID-19'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software